检索结果 - Fu, Zhiren
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction 由 Wang, Pusen, Que, Weitao, Li, Hao, Yan, Lvnan, Fu, Zhiren, Ye, Qifa, Chen, Guihua, Dou, Kefeng, Lu, Shichun, Yang, Zhanyu, Zhu, Zhijun, Peng, Zhihai, Zhong, Lin
出版 2017Text -
13
Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study 由 Ye, Sheng-Long, Yang, Jiamei, Bie, Ping, Zhang, Shuijun, Chen, Xiaoping, Liu, Fengyong, Liu, Luming, Zhou, Jie, Dou, Kefeng, Hao, Chunyi, Shao, Guoliang, Xia, Qiang, Chen, Yajin, Yang, Jijin, Deng, Xiaxing, Liu, Yunpeng, Yuan, Yunfei, Fu, Zhiren, Nakajima, Keiko, Lv, Zhengguang
出版 2018Text -
14
Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study 由 Ye, Sheng-Long, Chen, Xiaoping, Yang, Jiamei, Bie, Ping, Zhang, Shuijun, Liu, Fengyong, Liu, Luming, Zhou, Jie, Dou, Kefeng, Hao, Chunyi, Shao, Guoliang, Xia, Qiang, Chen, Yajin, Yang, Jijin, Deng, Xiaxing, Liu, Yunpeng, Yuan, Yunfei, Fu, Zhiren, Nakajima, Keiko, Yip, Christina S.M., Lu, Zhengguang
出版 2015Text